• December 22, 2017

    The ASSET Final Event was held in Rome, on October 30-31, to present all the main outcomes of the project. The event was targeted to a selected audience of EU stakeholders and policy makers and its aim was to enhance advocacy and intersectoral approach in a multisetting scenario applied to fostering preparedness and response toward Public Health Emergency of International Concern (PHEIC), like epidemics and even pandemics. In conjunction with the conference, a brokerage event also took place where coordinators of other H2020 projects with a focus on similar challenges were able to present themselves and show their expertise.

  • December 11, 2017

    We are going to face important challenges in public health and we need to improve the collaboration between scientists and policy-makers. Walter Ricciardi, President of the Italian National Institute of Health, explains why science-in-society is not just a slogan but a key perspective for citizens, scientists, healthcare workers and politicians.

  • October 24, 2017

    EUPATI, European Patients’ Academy on Therapeutic Innovation, is a patient-led initiative that uses training courses, educational material and an online public library for empowering patients to engage more effectively in the development and approval of new treatments and become true partners in pharmaceutical research and development. Filippo Buccella, chairman of the Italian Liaison Team explains to ASSET how this initiative can involve healthy citizens as well, improving preparedness to infectious outbreaks and other crises.

  • October 16, 2017

    The internet and social media era is both a great and a hard time to be an empowered patient or citizen. Every day everyone is overwhelmed by information, but also by misinformation. Discerning between the two is not so easy, according to Dennis Costello, Web Communications Senior Manager & RareConnect Leader at EURORDIS (Rare Diseases Europe). Best practices should be adopted by creators of contents and technical tools can further help in selecting them, but patients’ and consumers’ associations have a leading role in this, guiding the public so that they can make better decisions for themselves and their family.

  • October 11, 2017

    The growing role of Big Data in medicine raises an ethical issue for Responsible Research and Innovation: what about privacy and a possible misuse of such information? During “Shaping the Future of Pediatrics” congress in Rome, ASSET met Alberto Tozzi, Research area coordinator and Head of Digital Medicine and Telemedicine Unit at Ospedale Pediatrico Bambino Gesù, Rome. He suggests that technical solutions can help, but they are not enough, without a cooperation among all the actors (patients, family, hospital, authorities, and so on).

Gender Platform

Best Practice Platform

Gender Platform

Best Practice Platform

ASSET has been presenting at the international conference “Best practices in implementing the International Health Regulations (IHR)” that was held on June 7th and 8th, 2018 in Athens, Greece. This initiative has been promoted by several European Agencies (Directorate for Health and Food Safety – DG SANTE; Consumers, Health, Agriculture and Food Executive Agency – CHAFEA; European Centre for Disease Prevention and Control – ECDC) as well as by the hosting Greek institutions.

Concerning the fields of cross-border health threats preparedness and response and IHR implementation, the specific conference objectives were to present: • an overview of the current European framework • the monitoring and evaluation framework adopted by WHO • experiences and challenges in achieving interoperability • the results of EU-funded projects • lessons to Greek and European public health authorities in revising national plans and improving operational procedures.

Digital storytelling is an art-based research method that involves the creation of a short video (3-5 minutes) integrating multimedia materials like photos, people’s voices, drawings, and music. It has a great potential to elucidate complex narratives in a compelling manner, increase participant engagement, and enhance the meaning of research findings.

Social media and ASSET

Nowadays, social media is an increasingly common and integral part of all people's lives. In ASSET theory and practice about social media have been explored extensively over the four years of work (2014-2017). It has been done by studying to what extent epidemic or pandemic preparedness and response are covered by contents shared on the main social network platforms. Specific studies have been developed such as analysing the social accounts and profiles of relevant pharmaceutical companies. 

Work Packages

Dialogue & Participation
Study & Analysis
Action Plan Definition
Citizen Consultation
Mobilization and Mutual Learning
Policy Watch
Communication
Evaluation
Legacy
Management

Partners

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence